Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/23/2007 First Published: 1/1/1999


1.		Phase III Randomized Study of Low Molecular Weight Heparin (Dalteparin) Plus Standard Therapy Versus Standard Therapy Alone in Patients With Advanced Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				18 and over				NCI				NCCTG-979251 NCI-P98-0139, NCT00003674

Last Modified: 5/23/2007 First Published: 8/1/2000


2.		Phase III Study of Dalteparin to Prevent Catheter Related Complications in Cancer Patients Receiving Chemotherapy Through a Central Venous Catheter

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI, Pharmaceutical / Industry				UCLA-9910055 P-UPJOHN-98-FRAG-076, NCI-G00-1822, NCT00006083

Last Modified: 5/7/2007 First Published: 3/1/2002


3.		Phase III Randomized Study of Gemcitabine With or Without Dalteparin in Patients With Unresectable or Metastatic Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				18 and over				NCI				URCC-U2200 NCI-5012, NCI-CCC-99-45, NCI-P02-0212, URCC 5012, NCT00031837


4.		Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				Other				524E-CVD-0056-013 NCT00135876

Last Modified: 8/5/2008 First Published: 1/1/2002


5.		Phase II Study of Dalteparin and Conventional Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ECOG-E1F01 NCT00028678, E1F01


6.		Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Temporarily closed				18 to 75				Other				NRA6300011-FOCUS-II NCT00239980

Select All on One Page